CUSIP: 75525N107
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
54,177,528
-
Share change
-
+54,177,528
-
Total reported value
-
$1,201,178,191
-
Price per share
-
$22.20
-
Number of holders
-
68
-
Value change
-
+$1,201,178,320
-
Number of buys
-
68
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75525N107:
Institutional Holders of RAYZEBIO INC - COM (RYZB) as of Q3 2023
As of 30 Sep 2023,
RAYZEBIO INC - COM (RYZB) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,177,528 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, venBio Partners LLC, Versant Venture Management, LLC, VR Adviser, LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., Redmile Group, LLC, Samsara BioCapital, LLC, and HHLR ADVISORS, LTD..
This page lists
68
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.